Charles B. Nemeroff, M.D., Ph.D.

Charles Nemeroff is chair and professor with the Department of Psychiatry and Behavioral Sciences. He is also co-director of the Center for Psychedelic Research and Therapy. Additionally, he directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences.

Prior to joining Dell Med, Nemeroff served as chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine in Miami, Florida.

He received his medical degree and doctorate degrees in neurobiology from the University of North Carolina School of Medicine. After psychiatry residency training at UNC and Duke University, he held faculty positions at Duke University Medical Center and at Emory University School of Medicine before relocating to the University of Miami in 2009.

He has served as president of the American College of Psychiatrists and the American College of Neuropsychopharmacology, and he sits on the Scientific Advisory Board of the Brain and Behavioral Research Foundation. He is president-elect and a member of the board of directors of the Anxiety and Depression Association of America.

He has received a number of research and education awards, including the Kempf Award in Psychobiology, the Samuel Hibbs Award, the Research Mentoring Award, the Judson Marmor Award, the Vestermark Award and the Nasrallah Family Award for Advances in Psychiatric Neuroscience from the American Psychiatric Association; the Mood Disorders Award, the Bowis Award and the Dean Award from the American College of Psychiatrists; and the Julius Axelrod Award for mentoring from the American College of Neuropsychopharmacology. He was elected to the National Academy of Medicine in 2002. He was also named Alumnus of the Year from both the University of North Carolina and from the UNC School of Medicine. He received the doctorate honoris causa from Maimonides University in Buenos Aires in 2015.

He is a member of the APA Council on Research and chairs both the APA Research Colloquium for Young Investigators and the APA Work Group on Biomarkers and Novel Treatments.

He is co-director of the Texas Childhood Trauma Research Network.

His research is focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also conducted research on the role of mood disorders as a risk factor for major medical disorders including heart disease, diabetes and cancer. He has published more than 1,100 research reports and reviews, and his research is currently supported by grants from the National Institutes of Health.

He has also served on the Mental Health Advisory Council of National Institute of Mental Health and the Biomedical Research Council for NASA. He is co-editor-in-chief (with Alan F. Schatzberg, M.D.) of the Textbook of Psychopharmacology, published by the APA Books and soon to be in its sixth edition, and the second edition of the Textbook of Mood Disorders. He is the co-editor-in-chief of the journal Personalized Medicine in Psychiatry, published by Elsevier.